Karl-Olof Borg

Director/Board Member at BioCrine AB

83 year

Health Technology

Consumer Services

Profile

Karl-Olof Borg is currently a Director at BioCrine AB.
He was previously a Chairman at BioInvent International AB, and a Director at Eurocine Vaccines AB, Pharmexa A, Alligator Bioscience AB, 7TM A, and Galenica AB.
Borg holds a doctorate degree from the University of Uppsala.

Karl-Olof Borg active positions

Companies	Position	Start
BioCrine AB	Director/Board Member	11/05/2010

All active positions of Karl-Olof Borg

Former positions of Karl-Olof Borg

Companies	Position	End
Pharmexa A/S Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration	Chairman	15/06/2009
7TM A/S 7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark.	Director/Board Member	-
Galenica AB Galenica AB Pharmaceuticals: MajorHealth Technology Galenica AB develops and manufactures pharmaceutical drugs. It offers service to partners for the development of oral, dermal, nasal, rectal, pulmonary and parenteral formulations of small molecules to peptides/proteins and biologics. The company was founded in 1999 and is headquartered in Malmo, Sweden.	Director/Board Member	-
BIOINVENT INTERNATIONAL AB	Chairman	-
EUROCINE VACCINES AB	Director/Board Member	-

See the detail of Karl-Olof Borg's experience

Training of Karl-Olof Borg

University of Uppsala

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Karl-Olof Borg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
ALLIGATOR BIOSCIENCE AB	Health Technology
EUROCINE VACCINES AB	Health Technology
BIOINVENT INTERNATIONAL AB	Health Technology

Private companies	4
Pharmexa A/S Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration	Health Technology
Galenica AB Galenica AB Pharmaceuticals: MajorHealth Technology Galenica AB develops and manufactures pharmaceutical drugs. It offers service to partners for the development of oral, dermal, nasal, rectal, pulmonary and parenteral formulations of small molecules to peptides/proteins and biologics. The company was founded in 1999 and is headquartered in Malmo, Sweden.	Health Technology
BioCrine AB
7TM A/S 7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark.	Health Technology

See company connections

Stock Market
Insiders
Karl-Olof Borg